Literature DB >> 11450867

Elevated serum levels of interleukin-10 in children with acute rubella infection.

I Akaboshi1, I Nagayoshi, M Omura, K Iwaki.   

Abstract

Interleukin-10 (IL-10) is known to be an anti-inflammatory cytokine which inhibits cell growth and cytokine production of both Th1 and Th2 cells. Using a human IL-10 ELISA kit we investigated whether serum IL-10 levels increased during the acute and convalescent stages in 45 children with rubella infections. Serum levels of IL-10 were markedly elevated in rubella patients during the acute stage, compared with those at the convalescent stage and those in healthy age-matched children (mean +/- SEM): 18.5 +/- 3.4 vs. 6.0 +/- 0.6 vs. 7.9 +/- 1.3 pg/ml. IL-10 levels determined 5 d after the onset of the disease had returned to the normal range. In patients with rubella, there were significant negative correlations between serum IL-10 levels and both rubella virus-specific IgM and IgG antibodies. These findings suggest that IL-10 may play a role in the pathogenesis of acute rubella infections.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11450867     DOI: 10.1080/00365540152029945

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  8 in total

1.  Relationship between HLA polymorphisms and gamma interferon and interleukin-10 cytokine production in healthy individuals after rubella vaccination.

Authors:  Inna G Ovsyannikova; Robert M Jacobson; Jenna E Ryan; Neelam Dhiman; Robert A Vierkant; Gregory A Poland
Journal:  Clin Vaccine Immunol       Date:  2007-01-10

2.  SNP/haplotype associations in cytokine and cytokine receptor genes and immunity to rubella vaccine.

Authors:  Neelam Dhiman; Iana H Haralambieva; Richard B Kennedy; Robert A Vierkant; Megan M O'Byrne; Inna G Ovsyannikova; Robert M Jacobson; Gregory A Poland
Journal:  Immunogenetics       Date:  2010-03-10       Impact factor: 2.846

3.  Predominant inflammatory cytokine secretion pattern in response to two doses of live rubella vaccine in healthy vaccinees.

Authors:  Neelam Dhiman; Iana H Haralambieva; Robert A Vierkant; V Shane Pankratz; Jenna E Ryan; Robert M Jacobson; Inna G Ovsyannikova; Gregory A Poland
Journal:  Cytokine       Date:  2010-02-01       Impact factor: 3.861

Review 4.  T Lymphocytes as Measurable Targets of Protection and Vaccination Against Viral Disorders.

Authors:  Anne Monette; Andrew J Mouland
Journal:  Int Rev Cell Mol Biol       Date:  2018-10-24       Impact factor: 6.813

5.  Correlation between rubella antibody levels and cytokine measures of cell-mediated immunity.

Authors:  Pritish K Tosh; Richard B Kennedy; Robert A Vierkant; Robert M Jacobson; Gregory A Poland
Journal:  Viral Immunol       Date:  2009-12       Impact factor: 2.257

6.  Associations between markers of cellular and humoral immunity to rubella virus following a third dose of measles-mumps-rubella vaccine.

Authors:  Stephen N Crooke; Inna G Ovsyannikova; Richard B Kennedy; Nathaniel D Warner; Gregory A Poland
Journal:  Vaccine       Date:  2020-11-04       Impact factor: 3.641

7.  Influence of host genetic variation on rubella-specific T cell cytokine responses following rubella vaccination.

Authors:  Inna G Ovsyannikova; Jenna E Ryan; Robert A Vierkant; Megan M O'Byrne; V Shane Pankratz; Robert M Jacobson; Gregory A Poland
Journal:  Vaccine       Date:  2009-02-05       Impact factor: 3.641

8.  Cytokine profile after rubella vaccine inoculation: evidence of the immunosuppressive effect of vaccination.

Authors:  Alexander L Pukhalsky; Galina V Shmarina; Maria S Bliacher; Irina M Fedorova; Anna P Toptygina; Julia J Fisenko; Vladimir A Alioshkin
Journal:  Mediators Inflamm       Date:  2003-08       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.